Clinical Trials Directory

Trials / Unknown

UnknownNCT01473849

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients

Non-interventional, Prospective Study to Evaluate the Impact of CMV Replication Over Hepatitis C Recurrence in Liver Transplant Recipients

Status
Unknown
Phase
Study type
Observational
Enrollment
179 (estimated)
Sponsor
Sociedad Española de Trasplante Hepático · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The relationship between cytomegalovirus infection and recurrence of hepatitis C in liver transplant recipients remains controversial. Although some studies (Teixeira et al., 2000; Singh et al., 2005)have not found an association between recurrence of hepatitis C and CMV infection, studies such as Rosen et al. show that 50% of patients with CMV infection suffered cirrhosis durig follow-up period, while between not-infected patients the rate was 11%. To clarify this question, a non-interventional study will be carried out in order to assess if CMV replication is a risk factor for graft dysfunction in liver transplant recipients.

Conditions

Timeline

Start date
2010-05-01
Primary completion
2013-03-01
Completion
2013-04-01
First posted
2011-11-17
Last updated
2012-12-20

Locations

13 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01473849. Inclusion in this directory is not an endorsement.

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients (NCT01473849) · Clinical Trials Directory